http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012157674-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_858d5f920f452c89618540507544e4b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa4e178f27fa8a20765feb4f785d1a9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24f1fd0c9c3a9687f506cf1465704843 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0284a3a0d4b6e5a6d77c03d6d7f7b866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c5598aec29e4c200163d56da5945dd9 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd3b6b6c0e310520f52728956d3eeafd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e77bc1819f6a8af89af1ac4e8b17c34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce46f9cadbbfddf4fbf7f9976ca79fa1 |
| publicationDate | 2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2012157674-A1 |
| titleOfInvention | Cyclic peptide compound or pharmacologically acceptable salt thereof, method for producing cyclic peptide compound or pharmacologically acceptable salt thereof, and use of cyclic peptide compound or pharmacologically acceptable salt thereof |
| abstract | Provided are: a cyclic peptide compound which is capable of suppressing parakeratosis of the skin or a pharmacologically acceptable salt of the cyclic peptide compound; and a method for producing the cyclic peptide compound or a pharmacologically acceptable salt of the cyclic peptide compound. The present invention is a cyclic peptide compound which is represented by formula (I) (SEQ ID NO: 1) or a pharmacologically acceptable salt of the cyclic peptide compound. (In the formula, Xaa 1 represents an optionally substituted alanyl group or glycyl group; Xaa 2 represents an optionally substituted isoleucyl group or leucyl group; Xaa 3 represents an optionally substituted glutamyl group or aspartyl group; Xaa 4 represents an optionally substituted prolyl group or glycyl group; Xaa 5 represents an optionally substituted glutaminyl group or asparaginyl group; Xaa 6 represents an optionally substituted lysyl group or arginyl group; R 1 represents a group represented by formula (II) (wherein n represents an integer of 1-10); m represents an integer of 0 or 1; R 2 represents a cystine residue; and l represents an integer of 0 or 1. In this connection, m and l are not 0 at the same time.) |
| priorityDate | 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.